Site updated at Wednesday, 22 June 2016

Living with Dementia


Flaw in Alzheimer’s drug trial test

New research led by Plymouth University Peninsula Schools of Medicine and Dentistry suggests that the cognitive test used in Alzheimer’s drug trials is flawed.

The current standard cognitive test for the disease is the ADAS Cog. The new research, published as two studies in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, investigates… Flaw in Alzheimer’s drug trial test   


peripheral arterial disease1 - bradykinesia1 - alzheimer sufferer1 - genetic evidence1 - dementia and down’s syndrome1 - decline of memory1 - neurofibrillary tangle1 - dementia awareness week1 - late-onset alzheimers disease1 - national alzheimer's project act1 - islet amyloid polypeptide1 - antioxidants1 - spect1 - microrna1 - amyloid-beta4 - physical discomfort1 - brain cell damage2 - movement tremors1 - behavioral signs1 - the gerontologist1 - early-onset dementia2 - stage dementia1 - impassable plaques1 - moderate parkinson's disease1 - psychiatrist's bible1 - frontotemporal degeneration1 - ireland's national dementia strategy1 - decline in cognitive functioning1 - gammagard1 - cognitive performance1 -